Results 111 to 120 of about 20,878 (216)

A New Targeted Therapy Strategy for Lymphoma

MedComm, Volume 6, Issue 12, December 2025.
Robert Peter Gale
wiley   +1 more source

Ibrutinib‐induced severe liver injury [PDF]

, 2017
Amara Nandikolla, Olga Derman, Deborah Nautsch, Qiang Liu, Hatef Massoumi, Sangeetha Venugopal, Ira Braunschweig, Murali Janakiram   +7 more
openalex   +1 more source

Life after ibrutinib? A new unmet need in CLL [PDF]

, 2015
Javier Pinilla‐Ibarz, Julio C. Chávez
openalex   +1 more source

Hope for high risk chronic lymphocytic leukemia after ibrutinib failure

, 2018
Ohad Benjamini
openalex   +1 more source

Martin P, Bartlett NL, Blum KA, et al. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma. Blood. 2019;133(11):1201-1204. [PDF]

, 2019

openalex   +1 more source

CAPTIVATE PRIMARY ANALYSIS OF FIRST‐LINE TREATMENT WITH FIXED‐DURATION IBRUTINIB PLUS VENETOCLAX FOR CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL) [PDF]

, 2021
Constantine S. Tam, John N. Allan, Tanya Siddiqi, Thomas J. Kipps, Ryan Jacobs, Stephen Opat, Paul M. Barr, Alessandra Tedeschi, Livio Trentin, Rajat Bannerji, Sharon Jackson, Bryone J. Kuss, Carol Moreno, E. Szafer-Glusman, Kristin Russell, Cathy Zhou, Joi Ninomoto, James P. Dean, Paolo Ghia, William G. Wierda   +19 more
openalex   +1 more source

Supplementary Table S1 from B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy [PDF]

Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Susan O’Brien, Dan Jones, Leo W.K. Cheung, Kevin Kwei, Adrian Wiestner   +7 more
openalex   +1 more source

Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants [PDF]

, 2015
Jan de Jong, Donna Skee, Joe Murphy, Juthamas Sukbuntherng, Peter Hellemans, Johan W. Smit, Ronald de Vries, Juhui James Jiao, Jan Snoeys, Erik Mannaert   +9 more
openalex   +1 more source

Correction: Clinical outcomes of newly diagnosed PCNSL treated with rituximab-methotrexate-cytarabine with or without ibrutinib: a retrospective study [PDF]

Wenhua Wang, Bingyi Wang, Yifei Sun, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Zheng Song, Wei Li, Xudong Zhang, Lanfang Li, Xianhuo Wang, Huilai Zhang   +11 more
openalex   +1 more source

Rituximab Ibrutinib Lenalidomide (R2I) Combination for Primary or Secondary Large B-Cell CNS Lymphoma: Last Resort or Bridge to Cellular Therapy? [PDF]

, 2023
Ariel Perez Perez, Tiba Al Sagheer, George Nahas, Muni Rubens, Kristie Lopes, Yazmín Odia, Manmeet S. Ahluwalia, Zhijian Chen, Yuliya Linhares   +8 more
openalex   +1 more source